comprehensive -WSS

comprehensive

author：explore 2025-08-20 09:41:41 - browse：638

Illustration of a person talking with a huge speech bubble over his head. -- health tech coverage from STAT — Mike Reddy for STAT

The health care sector is a notorious laggard when it comes to technology. It was slow to use computers, digitize patient data, and share information electronically. While most of the world instantly interacts via Zoom and Slack, hospitals — even today — are still sending faxes.

But something different is happening with generative AI.

Health systems, drugmakers, and insurers are racing to build the technology into their operations, aligning themselves with corporate giants such as Microsoft, Google, and Nvidia, whose executives speak about each incremental advancement of AI as an earth-shattering event. “The generative AI revolution is here,” Jensen Huang, 61, Nvidia’s leather-jacket-clad CEO, declared during the company’s GTC conference in San Jose, Calif., last week.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Free medical tuition alone isn't enough to close gaps in primary care

WSS

Abbott's new stent may help patients with peripheral artery disease

FDA approves Recor Medical high blood pressure device

CVS is willing to dump 10% of its Medicare Advantage members

HPV cancer vaccine study demonstrates efficacy

STAT Executive Editor Rick Berke on STAT's 8th birthday

Galapagos to make CAR

entertainment

comprehensive

knowledge

Duchenne breakthrough therapy leaves behind pioneering families

UCSF medical school apologizes for unethical prisoner experiments

In Memoriam: Notable people who died in 2023

The Sacklers, horror, and ‘The Fall of the House of Usher’

Psychedelics group wrestles with new pharma identity

Removing probiotics from the NICU could threaten preemies' health

As demand for Covid shots wanes, Moderna seeks its next success

As H5N1 spreads in cows, experts warn against drinking raw milk

Apple is now the first public company to be valued at $3 trillion

Abbott's new stent may help patients with peripheral artery disease

explore

Oak Street deal isn't the answer to health care's woes

Diversify hospital leadership teams to protect BIPOC patient health

ALS treatment from Biogen, Ionis fails in study

FDA approves potent Eli Lilly obesity drug, Zepbound

ALS treatment from Biogen, Ionis fails in study

Sanofi CEO defends move to abandon profit guidance, boost research

leisure time

focus

entertainment

leisure time